Holly Hanson, MD
Dermatology · Eden Prairie, MNNPI 1023337946
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations.
Across 57 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$102
- LEO Pharma Inc.$76
- Sanofi$68
- UCB, Inc.$65
- Lilly USA, LLC$63
- E.r. Squibb & Sons, L.L.C.$63
- plus $508 from 19 others
What the payments were for
- Food & beverage$91597%
- Education$303%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $102 |
| LEO Pharma Inc. | 5 | $76 |
| Sanofi | 4 | $68 |
| UCB, Inc. | 2 | $65 |
| Lilly USA, LLC | 4 | $63 |
| E.r. Squibb & Sons, L.L.C. | 4 | $63 |
| Galderma Laboratories, L.p. | 4 | $55 |
| Sun Pharmaceutical Industries Inc. | 3 | $50 |
| Amgen | 3 | $46 |
| Medline Industries LP | 1 | $43 |
| Arcutis Biotherapeutics, Inc. | 3 | $38 |
| Incyte Corporation | 2 | $32 |
| Strata Skin Sciences, Inc. | 3 | $31 |
| Johnson & Johnson | 2 | $31 |
| VYNE Pharmaceuticals Inc. | 1 | $23 |
| Krystal Biotech Inc | 1 | $21 |
| Biofrontera Inc. | 1 | $19 |
| AbbVie | 1 | $19 |
| DUSA Pharmaceuticals, Inc. | 1 | $18 |
| Dermavant Sciences, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $13 |
| Promius Pharma LLC | 1 | $13 |
| Organon | 1 | $5 |
How this compares
$945 in reported general payments places this provider in the 75th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcipotriene | 19 | $8,019 |
| Metronidazole | 53 | $2,181 |
| Fluorouracil | 25 | $1,778 |
| Fluocinonide | 48 | $1,655 |
| Clobetasol Propionate | 33 | $1,418 |
| Desonide | 26 | $1,138 |
| Ketoconazole | 69 | $924 |
| Tretinoin | 12 | $908 |
| Betamethasone Dipropionate | 21 | $853 |
| Triamcinolone Acetonide | 57 | $673 |
| Minoxidil | 45 | $433 |
| Doxycycline Monohydrate | 17 | $423 |
| Ciclopirox | 18 | $196 |
| ValacyclovirValacyclovir Hcl | 14 | $172 |
| Dutasteride | 11 | $139 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Eden Prairie
- Kristina ShafferEagan$538K
- Margareth Pierre-LouisMinneapolis$439K
- Maria HordinskyMinneapolis$85K
- Afsaneh AlaviRochester$71K
- Todd SeelhammerSaint Paul$63K
- Brittney SchultzMinneapolis$52K
- David PearsonMinneapolis$46K
- Phillip EckerWayzata$31K
- Noah GoldfarbMinneapolis$30K
- Saranya WylesRochester$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.